Publicaciones (15) Publicaciones de CRISTINA BENITO VILLALVILLA

2024

  1. Deciphering the factors determining the differentiation of autoreactive thymocytes into regulatory T cells

    Allergy: European Journal of Allergy and Clinical Immunology

  2. The Role of Regulatory T Cells in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2024

    International Archives of Allergy and Immunology

2023

  1. Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-α production and FOXP3+ Treg generation

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 4, pp. 1060-1072

  2. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Allergoid-mannan conjugates imprint tolerogenic features in human macrophages

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 1, pp. 212-222.e9

2021

  1. Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 90-113

  2. Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs

    European Respiratory Journal

2020

  1. A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections

    Frontiers in Immunology, Vol. 11

  2. Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 3, pp. 648-659

2019

  1. Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 3, pp. 432-448

2018

  1. Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways

    European Journal of Immunology, Vol. 48, Núm. 1, pp. 180-193

  2. Novel vaccines targeting dendritic cells by coupling allergoids to mannan

    Allergo Journal International, Vol. 27, Núm. 8, pp. 256-262

  3. Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 875-884

2017

  1. MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88

    Mucosal Immunology, Vol. 10, Núm. 4, pp. 924-935